{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T20:12:13Z","timestamp":1694635933225},"reference-count":58,"publisher":"Radiation Research Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiation Research"],"published-print":{"date-parts":[[2009,6]]},"DOI":"10.1667\/rr1576.1","type":"journal-article","created":{"date-parts":[[2009,6,11]],"date-time":"2009-06-11T16:22:22Z","timestamp":1244737342000},"page":"725-734","source":"Crossref","is-referenced-by-count":2,"title":["Transient Dephosphorylation of p53 Serine 376 as an Early Response to Ionizing Radiation"],"prefix":"10.1667","volume":"171","author":[{"given":"Raymond L.","family":"Warters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David K.","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gwen F.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jesse D.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne E.","family":"Cress","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1243","reference":[{"key":"i0033-7587-171-6-725-b01","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81871-1"},{"key":"i0033-7587-171-6-725-b02","doi-asserted-by":"publisher","DOI":"10.1101\/gad.12.19.2973"},{"key":"i0033-7587-171-6-725-b03","doi-asserted-by":"crossref","unstructured":"Lavin, M. F. and N. Gueven. The complexity of p53 stabilization and activation. Cell Death Differ. 13:941\u2013950.2006.","DOI":"10.1038\/sj.cdd.4401925"},{"key":"i0033-7587-171-6-725-b04","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(92)90593-2"},{"key":"i0033-7587-171-6-725-b05","doi-asserted-by":"crossref","unstructured":"Hollander, M. C., I. Alamo, J. Jackman, O. W. McBride, and A. J. Fornace. Analysis of the mammalian gadd45 gene and its response to DNA damage. J. Biol. Chem. 268:24385\u201324393.1993.","DOI":"10.1016\/S0021-9258(20)80537-7"},{"key":"i0033-7587-171-6-725-b06","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90500-P"},{"key":"i0033-7587-171-6-725-b07","unstructured":"Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304\u20136311.1991."},{"key":"i0033-7587-171-6-725-b08","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(93)90496-D"},{"key":"i0033-7587-171-6-725-b09","unstructured":"Price, B. D. and S. K. Calderwood. Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters. Oncogene 8:3055\u20133062.1993."},{"key":"i0033-7587-171-6-725-b10","unstructured":"Kastan, M. B., O. Onyekwere, D. Sidransky, B. Vogelstein, and R. W. Craig. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51:6304\u20136311.1991."},{"key":"i0033-7587-171-6-725-b11","doi-asserted-by":"crossref","unstructured":"Maltzman, W. and L. Czyzyk. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol. Cell. Biol. 4:1689\u20131694.1984.","DOI":"10.1128\/MCB.4.9.1689"},{"key":"i0033-7587-171-6-725-b12","doi-asserted-by":"crossref","unstructured":"Nelson, W. G. and M. B. Kastan. DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways. Mol. Cell. Biol. 14:1815\u20131823.1994.","DOI":"10.1128\/MCB.14.3.1815"},{"key":"i0033-7587-171-6-725-b13","doi-asserted-by":"crossref","unstructured":"Graeber, T. G., J. F. Peterson, M. Tsai, A. J. Fornace, and A. J. Giaccia. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status. Mol. Cell. Biol. 14:6264\u20136277.1994.","DOI":"10.1128\/MCB.14.9.6264"},{"key":"i0033-7587-171-6-725-b14","unstructured":"Nigro, J. M., K. D. Aldape, S. M. Hess, and T. D. Tlsty. Cellular adhesion regulates p53 protein levels in primary human keratinocytes. Cancer Res. 57:3635\u20133639.1997."},{"key":"i0033-7587-171-6-725-b15","doi-asserted-by":"crossref","unstructured":"Linke, S. P., K. C. Clarkin, A. DiLeonardo, A. Tsou, and G. M. Wahl. A reversible, p53-dependent G0\/G1cell cycle arrest induced by ribonucleotide depletion in the absence of detectable DNA damage. Genes Dev. 10:934\u2013947.1996.","DOI":"10.1101\/gad.10.8.934"},{"key":"i0033-7587-171-6-725-b16","unstructured":"Hainaut, P. and J. Milner. Redox modulation of p53 conformation and sequence-specific DNA binding in vitro. Cancer Res. 53:4469\u20134473.1993."},{"key":"i0033-7587-171-6-725-b17","doi-asserted-by":"crossref","unstructured":"Huang, L. C., K. C. Clarkin, and G. M. Wahl. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc. Natl. Acad. Sci. USA 93:4827\u20134832.1996.","DOI":"10.1073\/pnas.93.10.4827"},{"key":"i0033-7587-171-6-725-b18","unstructured":"Wahl, G. M., S. P. Linke, T. G. Paulson, and L. C. Huang. Maintaining genetic stability through TP53 mediated checkpoint control. Cancer Surv. 29:183\u2013219.1997."},{"key":"i0033-7587-171-6-725-b19","doi-asserted-by":"crossref","unstructured":"Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. Regulation of the specific DNA binding function of p53. Cell 71:875\u2013886.1992.","DOI":"10.1016\/0092-8674(92)90562-Q"},{"key":"i0033-7587-171-6-725-b20","doi-asserted-by":"crossref","unstructured":"Wang, Y. and W. Eckhart. Phosphorylation sites in the amino-terminal region of mouse p53. Proc. Natl. Acad. Sci. USA 89:4231\u20134235.1992.","DOI":"10.1073\/pnas.89.10.4231"},{"key":"i0033-7587-171-6-725-b21","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80416-X"},{"key":"i0033-7587-171-6-725-b22","doi-asserted-by":"crossref","unstructured":"Siliciano, J. D., C. E. Canman, Y. Taya, K. Sakaguchi, E. Appella, and M. B. Kastan. DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11:3471\u20133481.1997.","DOI":"10.1101\/gad.11.24.3471"},{"key":"i0033-7587-171-6-725-b23","doi-asserted-by":"crossref","unstructured":"Shieh, S. Y., Y. Taya, and C. Prives. DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization. EMBO J. 18:1815\u20131823.1999.","DOI":"10.1093\/emboj\/18.7.1815"},{"key":"i0033-7587-171-6-725-b24","doi-asserted-by":"crossref","unstructured":"Unger, T., T. Juven-Gershon, E. Moallem, M. Berger, R. Vogt Sionov, G. Lozano, M. Oren, and Y. Haupt. Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2. EMBO J. 18:1805\u20131814.1999.","DOI":"10.1093\/emboj\/18.7.1805"},{"key":"i0033-7587-171-6-725-b25","doi-asserted-by":"crossref","unstructured":"Hirao, A., Y. Kong, S. Matsuoka, A. Wakeman, J. Ruland, H. Yoshida, D. Liu, S. J. Elledge, and T. W. Mak. DNA damage-induced activation of p53 by the checkpoint kinase Chk2. Science 287:1824\u20131827.2000.","DOI":"10.1126\/science.287.5459.1824"},{"key":"i0033-7587-171-6-725-b26","doi-asserted-by":"crossref","unstructured":"Honda, R., H. Tanaka, and H. Yasuda. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 420:25\u201327.1997.","DOI":"10.1016\/S0014-5793(97)01480-4"},{"key":"i0033-7587-171-6-725-b27","doi-asserted-by":"crossref","unstructured":"Haupt, Y., R. Maya, A. Kazaz, and M. Oren. Mdm2 promotes the rapid degradation of p53. Nature 387:296\u2013299.1997.","DOI":"10.1038\/387296a0"},{"key":"i0033-7587-171-6-725-b28","doi-asserted-by":"crossref","unstructured":"Kubbutat, M. H. G., S. N. Jones, and K. H. Vousden. Regulation of p53 stability by Mdm2. Nature 387:299\u2013303.1997.","DOI":"10.1038\/387299a0"},{"key":"i0033-7587-171-6-725-b29","doi-asserted-by":"crossref","unstructured":"Fisher, D. E. Apoptosis in cancer therapy: crossing the threshold. Cell 78:539\u2013542.1994.","DOI":"10.1016\/0092-8674(94)90518-5"},{"key":"i0033-7587-171-6-725-b30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8493"},{"key":"i0033-7587-171-6-725-b31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1905840"},{"key":"i0033-7587-171-6-725-b32","doi-asserted-by":"crossref","unstructured":"Lavine, A. J., J. Momand, and C. A. Finlay. The p53 tumour suppressor gene. Nature 351:453\u2013456.1991.","DOI":"10.1038\/351453a0"},{"key":"i0033-7587-171-6-725-b33","doi-asserted-by":"crossref","unstructured":"Moll, U. M., G. Riou, and A. J. Levine. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc. Natl. Acad. Sci. USA 89:7262\u20137266.1992.","DOI":"10.1073\/pnas.89.15.7262"},{"key":"i0033-7587-171-6-725-b34","unstructured":"Vogan, K., M. Bernstein, J. M. Lecler, L. Brisson, J. Brossard, G. M. Brodeur, J. Pelletier, and P. Gros. Absence of p53 gene mutations in primary neuroblastomas. Cancer Res. 53:5269\u20135373.1993."},{"key":"i0033-7587-171-6-725-b35","unstructured":"Komuro, H., Y. Hayashi, M. Kawamura, K. Hayashi, Y. Kaneko, S. Kamoshita, R. Hanada, K. Yamamoto, T. Hongo, and M. Yamada. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res. 53:4053\u20134288.1993."},{"key":"i0033-7587-171-6-725-b36","doi-asserted-by":"crossref","unstructured":"Schlamp, C. L., G. L. Poulsen, T. M. Norks, and R. W. Nickells. Nuclear exclusion of wild-type p53 in immortalized human retinoblastoma cells. J. Natl. Cancer Inst. 89:1530\u20131536.1997.","DOI":"10.1093\/jnci\/89.20.1530"},{"key":"i0033-7587-171-6-725-b37","unstructured":"Goldman, S. C., C. Y. Chen, T. J. Lansing, T. M. Gilmer, and M. B. Kastan. The p53 signal transduction pathway is intact in human neuroblastoma despite cytoplasmic localization. Am. J. Pathol. 148:1381\u20131385.1996."},{"key":"i0033-7587-171-6-725-b38","unstructured":"Martinez, J. D., M. E. Pennington, M. T. Craven, R. L. Warters, and A. E. Cress. Free radicals generated by ionizing radiation signal nuclear translocation of p53. Cell Growth Differ. 8:941\u2013949.1997."},{"key":"i0033-7587-171-6-725-b39","doi-asserted-by":"crossref","unstructured":"Jasty, R., J. Lu, T. Irwin, S. Suchard, M. G. Clarke, and V. P. Castle. Role of p53 in the regulation of irradiation-induced apoptosis in neuroblastoma cells. Mol. Genet. Metab. 65:155\u2013164.1998.","DOI":"10.1006\/mgme.1998.2747"},{"key":"i0033-7587-171-6-725-b40","doi-asserted-by":"crossref","unstructured":"Ronca, F., K. S. Y. Yee, and V. C. Yu. Retinoic acid confers resistance to p53-dependent apoptosis in SH-SY5Y neuroblastoma cells by modulating nuclear import of p53. J. Biol. Chem. 274:18128\u201318134.1999.","DOI":"10.1074\/jbc.274.25.18128"},{"key":"i0033-7587-171-6-725-b41","doi-asserted-by":"crossref","unstructured":"Moll, U. M., A. G. Ostermeyer, R. Haladay, B. Winkfield, M. Frazier, and G. Zambetti. Cytoplasmic sequestration of wild-type p53 protein impairs the G1checkpoint after DNA damage. Mol. Cell Biol. 16:1126\u20131137.1996.","DOI":"10.1128\/MCB.16.3.1126"},{"key":"i0033-7587-171-6-725-b42","unstructured":"McKenzie, P. P., S. M. Guichard, D. S. Middlemas, R. A. Ashmun, M. K. Danks, and L. C. Harris. Wild-type p53 can induce p21 and apoptosis in neuroblastoma cells but the DNA damage-induced G1checkpoint function is attenuated. Clin. Cancer Res. 5:4199\u20134207.1999."},{"key":"i0033-7587-171-6-725-b43","doi-asserted-by":"crossref","unstructured":"O'Neill, F. J., Y. Hu, T. Chen, and H. Carney. Identification of p53 unbound to T-antigen in human cells transformed by simian virus 40 T-antigen. Oncogene 14:955\u2013965.1997.","DOI":"10.1038\/sj.onc.1200913"},{"key":"i0033-7587-171-6-725-b44","doi-asserted-by":"crossref","unstructured":"Waterman, M. J. F., E. S. Stavridi, L. F. Waterman, and T. D. Halazonetis. ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat. Genet. 19:175\u2013178.1998.","DOI":"10.1038\/542"},{"key":"i0033-7587-171-6-725-b45","doi-asserted-by":"crossref","unstructured":"Chandar, N., B. Billig, J. McMaster, and J. Novak. Inactivation of p53 gene in human and murine osteosarcoma cells. Br. J. Cancer 65:208\u2013214.1992.","DOI":"10.1038\/bjc.1992.43"},{"key":"i0033-7587-171-6-725-b46","doi-asserted-by":"crossref","unstructured":"Ishihara, H., B. L. Martin, D. L. Brautigan, H. Karaki, H. Ozaki, Y. Kato, N. Fusetani, S. Watabe, K. Hashimoto, and D. J. Harshorne. Calyculin A and okadaic acid: inhibitors of protein phosphatase activity. Biochem. Biophys. Res. Commun. 159:871\u2013877.1989.","DOI":"10.1016\/0006-291X(89)92189-X"},{"key":"i0033-7587-171-6-725-b47","doi-asserted-by":"crossref","unstructured":"Takenaka, I., F. Morin, B. R. Seizinger, and N. Kley. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270:5405\u20135411.1995.","DOI":"10.1074\/jbc.270.10.5405"},{"key":"i0033-7587-171-6-725-b48","doi-asserted-by":"publisher","DOI":"10.1016\/S0079-6603(08)60611-X"},{"key":"i0033-7587-171-6-725-b49","doi-asserted-by":"publisher","DOI":"10.2307\/3575026"},{"key":"i0033-7587-171-6-725-b50","unstructured":"Ward, J. F., E. I. Joner, and W. F. Blakely. Effects of inhibitors of DNA strand break repair on HeLa cell radiosensitivity. Cancer Res. 44:59\u201363.1984."},{"key":"i0033-7587-171-6-725-b51","doi-asserted-by":"publisher","DOI":"10.2307\/3576104"},{"key":"i0033-7587-171-6-725-b52","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2264(200001)27:1<59::AID-GCC8>3.0.CO;2-9"},{"key":"i0033-7587-171-6-725-b53","doi-asserted-by":"publisher","DOI":"10.1126\/science.3975628"},{"key":"i0033-7587-171-6-725-b54","doi-asserted-by":"crossref","unstructured":"Mundt, M., T. Hupp, M. Fritsche, C. Merkle, S. Hansen, D. Lane, and B. Groner. Protein interactions at the carboxyl terminus of p53 result in the induction of its in vitro transactivation potential. Oncogene 15:237\u2013244.1997.","DOI":"10.1038\/sj.onc.1201174"},{"key":"i0033-7587-171-6-725-b55","doi-asserted-by":"crossref","unstructured":"Hupp, T. R., D. W. Meek, C. A. Midgley, and D. P. Lane. Regulation of the specific DNA binding function of p53. Cell 71:875\u2013886.1992.","DOI":"10.1016\/0092-8674(92)90562-Q"},{"key":"i0033-7587-171-6-725-b56","doi-asserted-by":"crossref","unstructured":"Webley, K., J. A. Bond, C. J. Jones, J. P. Blaydes, A. Craig, T. Jupp, and D. Wynford-Thomas. Posttranslational modifications of p53 in replicative senescence overlapping but distinct from those induced by DNA damage. Mol. Cell. Biol. 20:2803\u20132808.2000.","DOI":"10.1128\/MCB.20.8.2803-2808.2000"},{"key":"i0033-7587-171-6-725-b57","doi-asserted-by":"crossref","unstructured":"Kachnic, L. A., B. Wu, H. Wunsch, K. L. Mekeel, J. S. DeFrank, W. Tang, and S. N. Powell. The ability of p53 to activate downstream genes p21 (WAF1\/cip1) and MDM2, and cell cycle arrest following DNA damage is delayed and attenuated in scid cells deficient in the DNA-dependent protein kinase. J. Biol. Chem. 274:13111\u201313117.1999.","DOI":"10.1074\/jbc.274.19.13111"},{"key":"i0033-7587-171-6-725-b58","doi-asserted-by":"crossref","unstructured":"Price, W. A., C. C. Stobbe, S. J. Park, and J. B. Chapman. Radiosensitization of tumour cells by cantharidin and some analogues. Int. J. Radiat. Biol. 80:269\u2013279.2004.","DOI":"10.1080\/09553000410001679785"}],"container-title":["Radiation Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T08:07:39Z","timestamp":1633594059000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.bioone.org\/doi\/10.1667\/RR1576.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,6]]}},"alternative-id":["10.1667\/RR1576.1"],"URL":"https:\/\/doi.org\/10.1667\/rr1576.1","relation":{},"ISSN":["0033-7587","1938-5404"],"issn-type":[{"value":"0033-7587","type":"print"},{"value":"1938-5404","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,6]]}}}